Skip to main content
. 2003 Feb 19;138(4):554–563. doi: 10.1038/sj.bjp.0705042

Figure 4.

Figure 4

Original traces showing changes in heart rate (HR) and blood pressure (BP) induced by SN microinjection of (A) vehicle (aCSF with 10% DMSO), (B) the NK1 agonist [Sar9,Met(O2)11]SP (25 pmol), (C) the NK2 agonist [β-Ala8]NKA (4-10) (25 pmol) and (D) the NK3 agonist senktide (50 pmol) in SHR.